News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BSD Medical (BSDM) Announces BSD-2000 Marketing Approval Submission to Taiwan Food and Drug Administration by Linden Bioscience


5/13/2013 11:26:56 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that its exclusive Taiwan distributor Linden Bioscience Co., Ltd. (Linden), has submitted its BSD-2000 marketing approval application for the BSD-2000 Hyperthermia System (BSD-2000) to the Taiwan Food and Drug Administration (TFDA). The TFDA approval of the BSD-2000 could occur as early as November 2013.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES